Skip to main content
Veterinary Medicines

ATOPICA 10 mg soft capsules for dogs

Authorised
  • Ciclosporin

Product identification

Medicine name:
ATOPICA 10 mg soft capsules for dogs
ATOPLUS 10 mg capsule molli per cani
ATOPLUS 10 mg capsule molli per cani
Active substance:
  • Ciclosporin
Target species:
  • Dog
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Ciclosporin
    10.00
    milligram(s)
    /
    1.00
    Capsule
Pharmaceutical form:
  • Capsule, soft
Withdrawal period by route of administration:
  • Oral use
    • Dog
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QL04AD01
Authorisation status:
  • Valid
Authorised in:
  • Italy
Package description:
  • Box containing 60 capsules in 12 aluminium/aluminium blister packs
  • Box containing 30 capsules in 6 aluminium/aluminium blister packs
  • Box containing 15 capsules in 3 aluminium/aluminium blister packs

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Elanco GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
  • Elanco France S.A.S
Responsible authority:
  • MdS
Authorisation number:
This information is not available for this product.
Date of authorisation status change:
Reference member state:
  • Ireland
Procedure number:
  • IE/V/0880/001
Concerned member states:
  • Denmark
  • Finland
  • Italy
  • Luxembourg
  • Netherlands
  • Norway
  • Portugal
  • Spain
  • Sweden
  • United Kingdom (Northern Ireland)

Documents

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
Italian (PDF)
Published on: 20/06/2022
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."